EMD Serono, Inc.’s Post

This week Lori Lebson Senior Vice President, North America Medical Affairs and Venkat Thiruvallur, Senior Vice President, Head of U.S. Neurology & Immunology, attended the Pharma USA 2025 Conference sponsored by Reuters Events Pharma and participated in impactful panel discussions that focused on the role of technology and real-world evidence (RWE) in healthcare innovation. The discussions centered on how technology serves as a tool to empower our workforce, emphasizing the importance of upskilling and democratizing AI access. They also addressed the critical need for RWE to meet value demonstration demands and support insights generation across various functions. These are the conversations and convening that help to bring our vision to life as we aim to spark discovery and elevate humanity. #REpharmaUSA

  • No alternative text description for this image
Zheng Feng, PhD, MD

Head of Clinical Genomics, Clinical Measurements Sciences; EMD Serono is a subsidiary of Merck KGaA, Darmstadt, Germany

1w

Congrats! Lori Lebson

Deepak D.M. MD,MBA,PDCR

Medical affairs|| Clinical Development || Life Cycle Management|| Multiple therapy area experience|| Medical education and ethical medical communications|| Patient-centricity|| ||Passionate about digital health solutions

5d

Insightful

Like
Reply
Dr.Hemant Khanna

Director, Global Medical Affairs |Gene therapies|Ophthalmology| Neurology|Clinical Development | Life Cycle Management | Patient Oriented Programs

1w

Great discussion at conference

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics